Paradigm Immunotherapeutics, Inc
Paradigm Immunotherapeutics, Inc., based in Monrovia, CA, focuses on developing groundbreaking technologies aimed at combating BSL 3 and 4 infectious agents, including Ebola, as well as innovative treatments for immune-mediated diseases. The company operates at the forefront of medical advancements, although the co-development of intellectual property necessitates limited public disclosure.
For accredited investors, Paradigm provides access to essential materials such as a pitch deck, term sheet, team information, an executive summary, FAQs, and budget details from 2016-2018 through a designated platform. This approach underscores the company’s commitment to fostering investment in its pioneering scientific endeavors.
Generated from the website
Also at this address
You might also like
Partial Data by Infogroup (c) 2024. All rights reserved.